Compound ID | 2845
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor. Binds to elongation factor thermo-unstable (EF-Tu) inhibiting trans-translation |
| Target Pathogen: | Active against Bacillus anthracis, Shigella flexneri, and Mycobacterium smegmatis |
| Description: | Synthetic compound; tetrazole-based compound that inhibits trans-translation but not normal translation in protein synthesis |
| Institute where first reported: | Genomics Institute of the Novartis Research Foundation, San Diego, CA 92121; Emory Antibiotic Resistance Center (ARC), Emory University, Atlanta, Georgia, USA; Department of Chemistry, Emory University, Atlanta, Georgia, USA; Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania, USA |
| Year first mentioned: | 2013 |
| Development status: | Experimental |